186 related articles for article (PubMed ID: 33009579)
1. Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment-induced severe oral mucositis.
Palmier NR; Leme AFP; De Rossi T; Telles GP; Morais-Faria K; Kowalski LP; Marta GN; Brandão TB; Arany PR; Migliorati CA; Santos-Silva AR; Prado-Ribeiro AC
Support Care Cancer; 2021 Jun; 29(6):2939-2946. PubMed ID: 33009579
[TBL] [Abstract][Full Text] [Related]
2. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
3. Prospective study on health-related quality of life, oral mucositis and oral health on during treatment of head and neck cancer.
Karlsson C; Bohm N; Andersson JS; Finizia C; Almståhl A
BMC Oral Health; 2024 Jun; 24(1):697. PubMed ID: 38879501
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
Agurto MG; Carpenter GH; Bozorgi SS; Koller G; Fenlon M; Warburton F; Bruce K; Burke M; Banerjee A
BMC Oral Health; 2024 May; 24(1):630. PubMed ID: 38811865
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
[TBL] [Abstract][Full Text] [Related]
6. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients.
Oton-Leite AF; Silva GB; Morais MO; Silva TA; Leles CR; Valadares MC; Pinezi JC; Batista AC; Mendonça EF
Lasers Surg Med; 2015 Apr; 47(4):296-305. PubMed ID: 25824475
[TBL] [Abstract][Full Text] [Related]
7. Differences in the whole saliva baseline proteome profile associated with development of oral mucositis in head and neck cancer patients undergoing radiotherapy.
Jehmlich N; Stegmaier P; Golatowski C; Salazar MG; Rischke C; Henke M; Völker U
J Proteomics; 2015 Jul; 125():98-103. PubMed ID: 25997676
[TBL] [Abstract][Full Text] [Related]
8. Photobiomodulation reduces the impact of radiotherapy on oral health-related quality of life due to mucositis-related symptoms in head and neck cancer patients.
Martins AFL; Morais MO; de Sousa-Neto SS; de Jesus APG; Nogueira TE; Valadares MC; Freitas NMA; Batista AC; Leles CR; Mendonça EF
Lasers Med Sci; 2021 Jun; 36(4):903-912. PubMed ID: 33113075
[TBL] [Abstract][Full Text] [Related]
9. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Suzuki F; Nakamaru Y; Oridate N; Homma A; Nagahashi T; Yamaguchi S; Nishihira J; Furuta Y; Fukuda S
Oncol Rep; 2005 Jan; 13(1):59-64. PubMed ID: 15583802
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of photobiomodulation therapy in the management of oral mucositis in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials.
Shen B; Zhou Y; Wu D; Liu J
Head Neck; 2024 Apr; 46(4):936-950. PubMed ID: 38265122
[TBL] [Abstract][Full Text] [Related]
12. Patterns of oral mucositis in advanced oral squamous cell carcinoma patients managed with prophylactic photobiomodulation therapy-insights for future protocol development.
de Pauli Paglioni M; Faria KM; Palmier NR; Prado-Ribeiro AC; E Dias RB; da Graça Pinto H; Treister NS; Epstein JB; Migliorati CA; Santos-Silva AR; Brandão TB
Lasers Med Sci; 2021 Mar; 36(2):429-436. PubMed ID: 32627112
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
15. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
[TBL] [Abstract][Full Text] [Related]
16. Incidence of oral mucositis, its treatment and pain management in patients receiving cancer treatment at Radiation Oncology Departments in Spanish hospitals (MUCODOL Study).
Mañas A; Palacios A; Contreras J; Sánchez-Magro I; Blanco P; Fernández-Pérez C
Clin Transl Oncol; 2009 Oct; 11(10):669-76. PubMed ID: 19828409
[TBL] [Abstract][Full Text] [Related]
17. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck.
Reyes-Gibby CC; Wang J; Zhang L; Peterson CB; Do KA; Jenq RR; Shelburne S; Shah DP; Chambers MS; Hanna EY; Yeung SJ; Shete S
Cancer; 2020 Dec; 126(23):5124-5136. PubMed ID: 32888342
[TBL] [Abstract][Full Text] [Related]
18. Effect of photobiomodulation therapy on reducing the chemo-induced oral mucositis severity and on salivary levels of CXCL8/interleukin 8, nitrite, and myeloperoxidase in patients undergoing hematopoietic stem cell transplantation: a randomized clinical trial.
Salvador DRN; Soave DF; Sacono NT; de Castro EF; Silva GBL; E Silva LP; Silva TA; Valadares MC; Mendonça EF; Batista AC
Lasers Med Sci; 2017 Nov; 32(8):1801-1810. PubMed ID: 28664388
[TBL] [Abstract][Full Text] [Related]
19. A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients.
Taylor JK; Mady LJ; Baddour K; Iheagwara UK; Zhai S; Ohr JP; Zandberg DP; Gorantla VC; Ferris RL; Kim S; Duvvuri U; Kubik MW; Sridharan S; Johnson JT; Holeva KD; Quinn AE; Clump DA
World J Otorhinolaryngol Head Neck Surg; 2022 Dec; 8(4):345-354. PubMed ID: 36474663
[TBL] [Abstract][Full Text] [Related]
20. A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol.
Morais MO; Martins AFL; de Jesus APG; de Sousa Neto SS; da Costa AWF; Pereira CH; Oton-Leite AF; de Freitas NMA; Leles CR; Mendonça EF
Support Care Cancer; 2020 Sep; 28(9):4263-4273. PubMed ID: 31900618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
